Physalis angulata induces in vitro differentiation of murine bone marrow cells into macrophages by Bruno José da Silva et al.
da Silva et al. BMC Cell Biology 2014, 15:37
http://www.biomedcentral.com/1471-2121/15/37RESEARCH ARTICLE Open AccessPhysalis angulata induces in vitro differentiation
of murine bone marrow cells into macrophages
Bruno José Martins da Silva1,2, Ana Paula D Rodrigues2,3, Luis Henrique S Farias1,2, Amanda Anastácia P Hage1,2,
Jose Luiz M Do Nascimento4 and Edilene O Silva1,2*Abstract
Background: The bone marrow is a hematopoietic tissue that, in the presence of cytokines and growth factors,
generates all of the circulating blood cells. These cells are important for protecting the organism against pathogens
and for establishing an effective immune response. Previous studies have shown immunomodulatory effects of
different products isolated from plant extracts. This study aimed to evaluate the immunomodulatory properties of
aqueous Physalis angulata (AEPa) extract on the differentiation of bone marrow cells.
Results: Increased cellular area, higher spreading ability and several cytoplasmatic projections were observed in the
treated cells, using optical microscopy, suggesting cell differentiation. Furthermore, AEPa did not promote the
proliferation of lymphocytes and polymorphonuclear leukocytes, however promotes increased the number of
macrophages in the culture. The ultrastructural analysis by Transmission Electron Microscopy of treated cells showed
spreading ability, high number of cytoplasmatic projections and increase of autophagic vacuoles. Moreover, a high
level of LC3b expression by treated cells was detected by flow cytometry, suggesting an autophagic process. Cell
surface expression of F4/80 and CD11b also indicated that AEPa may stimulate differentiation of bone marrow cells
mainly into macrophages. In addition, AEPa did not differentiate cells into dendritic cells, as assessed by CD11c analysis.
Furthermore, no cytotoxic effects were observed in the cells treated with AEPa.
Conclusion: Results demonstrate that AEPa promotes the differentiation of bone marrow cells, particularly into
macrophages and may hold promise as an immunomodulating agent.
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The hematopoietic tissue, bone marrow, is responsible for
generating all circulating blood cells [1]. Hematopoietic
stem cells undergo the process of maturation and differen-
tiation in the presence of cytokines and growth factors
present in the marrow microenvironment, giving rise to
myeloid and lymphoid progenitor cells [2,3]. These mye-
loid progenitors, when stimulated, differentiate and give
rise to blood cells, macrophages and dendritic cells (DCs),
while the lymphoid lineage differentiates into T and B
lymphocytes, natural killers (NK) cells and DCs [4,5].* Correspondence: edilene@ufpa.br
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unless otherwise stated.The monocytes belong to the mononuclear phagocytic
system and constitute about 3 to 8% of circulating leu-
kocytes in the blood [6,7]. After three days in the circu-
lating blood, monocytes begin the migration process to
tissues where they differentiate into macrophages and
DCs [6,7]. During the differentiation of monocytes into
macrophages, several cellular changes are observed, such
as increased cell size, increased number of organelles and
the induction of the autophagic process [8,9]. Autophagy
is essential for monocyte-macrophage differentiation; re-
ports demonstrate that some monocytes cannot survive if
the autophagy process is blocked and, if they are to sur-
vive, the differentiation process becomes defective inhibit-
ing differentiation of cells into macrophages [9].
Macrophages express specific molecules on their sur-
face, including the F4/80 and CD11b/MAC-1 proteins,
which are markers of the differentiation process and
allow macrophages to differentiate into other cell typesl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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of cell adhesion and in the migration to sites of intracel-
lular pathogen invasion [10]. Macrophages are important
for maintaining an efficient innate immune response,
having the ability to migrate to the site of invasion, rec-
ognizing the aggressor, phagocytosing and eliminating
the pathogen [3,12].
In recent years, there has been a growing interest in
the use of natural products to induce proliferation and
differentiation of bone marrow cells [13-16]. In this con-
text, Physalis angulata (Pa), which is a herbaceous plant,
has been reported to possess several activities, among
them, diuretic, antipyretic, analgesic [17], antinociceptive,
anti-inflammatory and immunomodulatory [18,19] prop-
erties. Phytochemical studies of P. angulata demonstrate
that extracts from this plant contains glucocorticoids, fla-
vonoids, physalins (D, I, G, K, B, F, E), physagulins (E, F
and G), and withanolides [20,21]. It is possible that the
immunomodulatory effects of this plant may occur due
to hematopoietic-supportive activities, through the acti-
vation of resident macrophages, which undergo several
morphological changes, such as an increase in spread-
ing and adhesion abilities, phagocytosis activity, ROS
generation, antigen presentation and cytokine production.
Therefore, the aim of this study was to evaluate the modu-
latory activity of AEPa on the cell differentiation process
of monocyte-derived bone marrow cells in macrophages.
Methods
Preparation of the aqueous extract from roots of Physalis
angulata (AEPa)
Roots of the Physalis angulata (Solanaceae) plant were
collected in Pará state, Brazil. Roots were cut to produce
the aqueous extract. AEPa was prepared as described by
Bastos et al. [18]. The voucher specimen (no. 563) was de-
posited in the herbarium of the Emilio Goeldi Museum
(Belém, Pará, Brazil). One mg/mL of aqueous extract from
the root of Physalis angulata (AEPa) was dissolved in
Dulbecco’s Modified Eagle’s Medium (DMEM) or RPMI
and used as the standard solution for assays.
Bone marrow cells isolation
Bone marrow cells (BMCs) were isolated from the fe-
murs of male mice BALB/c (Mus musculus) aged 6–12
weeks. The animals were sacrificed in a CO2 chamber
(Insight®) and the femurs were dissected under laminar
flow and washed with sterile phosphate buffered saline
(PBS). The epiphyses were then removed [22], and cells
were homogenized and diluted in DMEM containing
10% FBS, maintained in 12, 24 or 96-well plates at 37°C
in a 5% CO2 atmosphere. The experiments and study
were carried out in accordance with current Brazilian
animal protection laws (Lei Arouca number 11.794/08)
in compliance with the National Council for the Controlof Animal Experimentation (CONCEA, Brazil). The
protocol was approved by the Committee on the Ethics
of Animal Experiments of the Federal University of Pará
(CEPAE/ICB/UFPA - grant number 086–12).
Treatment of bone marrow cells
BMCs were cultured in the presence of 100 μg/mL of
AEPa (1 mg/mL stock solution) for 24, 48, 72 and
96 hours. In some assays, BMCs were treated with 100
nM macrophage colony-stimulating factor (M-CSF), as
positive control for differentiation. M-CSF and AEPa
were added to the cultures every 24 hours until the end
of each test, without replacing the culture medium.
Cell viability tests
To assess the viability of the BMCs treated with AEPa,
three tests were performed as described below.
Method Thiazolyl Blue (MTT)
MTT is a soluble salt, which is converted by mitochon-
drial dehydrogenases into formazan blue crystal. This
assay is based on the mitochondrial-dependent reduc-
tion of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazo-
lium bromide (MTT) to formazan. The procedure was
performed according to Fotakis and Timbrell [23], with
some modifications.
BMCs were cultured and treated with 25, 50 or
100 μg/mL AEPa for 24, 48, 72 and 96 hours. Subse-
quently, cells were incubated with 0.5 mg/mL MTT di-
luted in PBS and incubated at 37°C in a humidified
atmosphere containing 5% CO2 for 3 hours. Two-hundred
μL of DMSO were added to each well to solubilize forma-
zan crystals and the plate was incubated under agitation
for 10 minutes. The resulting solution was read in a mi-
croplate reader (BIO-RAD Model 450 Microplate Reader)
and absorbance was recorded at an optical density (OD)
of 570 nm. As a negative control, cells were killed with a
15% solution of formaldehyde in PBS.
Detection of the mitochondrial membrane potential (JC-1)
JC-1 is a fluorescent dye that measures the mitochon-
drial membrane potential (ΔΨ) of cells. The loss of this
potential serves as an indicator of apoptosis, where this
dye remains in its monomeric form and emits a green
fluorescence. Living cells form the “J-aggregates” which
emit a red fluorescence.
BMCs were treated with 100 μg/mL AEPA for
96 hours. Subsequently, cells were incubated with JC-1
(1 μM) for 30 min at 37°C. After incubation, the cells
were washed and resuspended in PBS. Fluorescence data
were obtained using a flow cytometer (BD FACSCantoII
TM) at an excitation wavelength of 488 nm, where JC-1
monomers emit fluorescence at 529 nm and J-aggregates
emit at 590 nm. A total of 10.000 events were acquired
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ometer BD FACSCantoII. The data were analyzed using
WinMDI version 2.9 (Joseph Trotter) software. The
gate was determined using unstained BMCs controls
(Additional file 1). The data were analyzed using WinMDI
version 2.9 (Joseph Trotter) software.
Detection of apoptosis and necrosis of BMCs treated
with AEPa
For detection of apoptosis and necrosis of BMCs treated
with AEPA, Annexin V-FITC (Invitrogen) and PI (Sigma)
were used, respectively. BMCs were treated with 100 μg/
mL AEPa and cultured for 96 hours. After treatment,
these cells were incubated for 30 minutes with 10 μg/mL
Annexin V-FITC and then incubated with 25 μg/mL PI
for 30 minutes. Finally, the cells were washed with PBS
and data obtained by flow cytometry. A total of 10.000
events were acquired for each sample in the region that
corresponded to the BMCs and the gates were determined
using unstained controls (Additional file 1).
Light microscopy (LM)
BMCs were cultured and treated for 24, 48, 72 and
96 hours before dividing into three groups, control (non
treated cells), treated with AEPa and M-CSF. Cells were
fixed in a solution containing 3% paraformaldehyde in
PHEM buffer (5 mM magnesium chloride, 70 mM potas-
sium chloride, 10 mM EGTA, 20 mM HEPES, 60 mM
PIPES), 0.1 M pH 7.2, stained with Giemsa and covered
with Entellan® (Merck). Two hundred cells were counted
per coverslip. Differentiated cell types such as lymphocytes,
mononuclear phagocytes (monocytes and macrophages)
and polymorphonuclear (PMN) were identified according
to their morphological characteristics. Cells were counted
and analyzed using an Olympus BX41 microscope.
Morphometric analysis
The cytoplasmic area of the control group and treated
BMCs (100 μg/mL of AEPa for 96 hours) was analyzed
using the program Image J (NHI) software and images
were obtained by light microscopy. This analysis was
performed as described by Sokol et al. [24].
Transmission Electron Microscopy (TEM)
Control and treated BMCs were fixed with 2.5% glutaral-
dehyde and 4% paraformaldehyde in 0.1 M sodium caco-
dylate buffer, pH7.2. The cells were washed in the same
buffer and incubated in 1% osmium tetroxide and 0.8%
potassium ferricyanide for 1 hour. The cells were dehy-
drated in graded acetone (50%, 70%, 90% and 2× 100%)
and embedded in Epon resin (2:1, 1:1 and 1:2 - 100%
acetone: Epon). Thin sections were contrasted with 5%
uranyl acetate and lead citrate and finally observed with
a LEO 906 E Transmission Electron Microscope.Detection of LC3b protein by flow cytometry
Treated and untreated BMCs were fixed with 3% parafor-
maldehyde and 0.1 M PHEM buffer, pH 7.2, for 30 minutes.
Subsequently, cells were permeabilized with 0.1% Triton
X-100, washed in PBS and incubated with 50 mM NH4Cl
in PBS for 40 minutes.
The cells were incubated with polyclonal anti-LC3b
antibody (Invitrogen Molecular Probes®) diluted 1:1000 in
PBS with 1% BSA for 1 hour, then washed in PBS and in-
cubated with a fluorescent secondary antibody (Alexa
Fluor 488-labelled goat anti-rabbit IgG; Molecular Probes
Invitrogen®) diluted 1:100 in PBS for 30 minutes. Data
were obtained by flow cytometry (BD FACSCantoII) at an
excitation wavelength of 488 nm. The results were ana-
lyzed by WinMDI version 2.9 (Joseph Trotter). For induc-
tion of autophagy, BMCs were cultured for 96 hours,
washed with PBS and incubated for 3 hours with phos-
phate buffer, pH 7.2, at 37°C in 5% CO2 and used as a
positive control for the autophagic process.
Detection of cell surface markers by flow cytometry
Treated and untreated BMCs were fixed with 3% parafor-
maldehyde and 0.1 M PHEM buffer, pH 7.2, for 30 minutes.
Cells were washed in PBS, pH 8.0, and incubated with
50 mM NH4Cl in PBS for 40 minutes. Next, the cells were
incubated for 1 hour with anti-CD11c monoclonal anti-
body (DCs marker), anti-CD11b (Mac-1) and anti- F4/80
monoclonal antibody (mononuclear cells and macrophage
markers, respectively), diluted 1:50 in PBS. Subsequently,
cells were incubated with fluorescent secondary antibody
conjugated with PE-goat anti-rat IgG, diluted 1:50 in PBS
for 40 minutes. A positive control was treated with M-CSF
(100 mM) and also maintained in parallel. All experiments
were performed at least three times with treated and un-
treated cells. Data were obtained by flow cytometry (BD
FACSCantoII) at an excitation wavelength of 546 nm and
analyzed by WinMDI version 2.9 (Joseph Trotter) software.
Statistical Analysis
All experiments were performed in triplicate and the results
were analyzed by GraphPad Prism 5 (GraphPad Software,
La Jolla, CA, USA). The means and S.D. of at least three ex-
periments were determined. Analysis of variance (ANOVA)
and Student’s t-test were used to compare data. The Tukey
test was applied when necessary. All p-values <0.05 were
considered as statistically significant.
Results
Effect of AEPa on BMCs cell viability
BMCs were treated with 25, 50 and 100 μg/mL AEPa for
24-96 h and cell viability analyzed by the MTT assay
(Figure 1a). Alternatively, BMCs were treated with
100 μg/mL for 96 hours and loaded with JC-1 (Figure
1b1 and 1b2) or stained with PI and Annexin-V (Figure 1
Figure 1 Cellular viability of bone marrow cells (BMCs) treated with AEPa, as measured by MTT, JC-1, propidium iodide and annexin V
assays. a) Cell viability was determined using the MTT assay. Treatment of BMCs maintained in culture after 24, 48, 72 and 96 hours with different
concentrations of AEPa, (25, 50 and 100 μg/mL). Data are expressed as mean ± SD of three independent experiments. ANOVA followed by Tukey test,
p <0.05. b1-b2) Determination of mitochondrial membrane potential (Δψm) by flow cytometry. Δψm detected by JC-1 in untreated BMCs (b1) or treated
cells with 100 μg/mL of AEPa after 96 hours (b2) (results from 10.000 events analyzed). c1 and c2) Determination of apoptosis and/or necrosis analyzed
by flow cytometry. c1) Untreated cells. c2) BMCs treated with 100 μg/mL AEPa and maintained in culture after 96 hours. The percentages of apoptotic
and necrotic cells are presented in the dot plots and are representative of one of three independent experiments (results from 10.000 events analyzed).
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cells treated for 24, 48, 72 and 96 hours, when compared
to the control group, as shown by the MTT assay. Label-
ing with JC-1 and PI and annexin-V demonstrated that
treated cells remain viable following 96 hours of culture.Quantitative analysis of adherent cells
To evaluate the effect of AEPa on the BMCs, a quantita-
tive analysis was performed and identified the following
cell types, including lymphocytes, PMN and mono-
nuclear phagocytes.Figure 2 Differential cell count in BMCs cultures after 24, 48, 72 and
M-CSF and compared to the control group. a) Lymphocytes. Inset, lympho
b) Polymorphonuclear. Inset, showing polymorphonuclear (arrow), cells wit
phagocytes. Inset 1, showing monocyte, cell with a small cytoplasmic area
cell with a large nucleus and evident cytoplasm. The values are expressed a
by Tukey test, p <0.05.Lymphocytes
Lymphocytes were characterized as cells with a small cyto-
plasmic area and large nucleus. From 96 hour of treatment,
a reduction of 40% ± 8 in the number of lymphocytes was
observed when compared with untreated cells (Figure 2a).PMN cells
PMN cells have two or more nuclei arranged in the
cytoplasm. No significant difference was observed be-
tween the control group and the group treated with
AEPa for 96 hours (Figure 2b).96 hours. Cells were treated with 100 μg/mL of AEPa, 100 nM of
cytes (arrow), cells with a small cytoplasmic area and large nucleus.
h two or more nuclei arranged in the cytoplasm. c) Mononuclear
and nucleus in a horseshoe shape and, inset 2 showing macrophage,
s means ± SD and compared with the control group. ANOVA, followed
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Mononuclear cells constitute monocytes (cells with a small
cytoplasmic area and nucleus in a horse-shoe shape) and
macrophages (large nucleus and evident cytoplasm). A sig-
nificant increase in the number of cells with macrophage
characteristics was observed in the cultures treated with
AEPa (8% ± 3) for 96 hours, when compared to the control
group (Figure 2c).
AEPa induces morphological alterations and increases
cellular area in BMCs
Control and BMCs treated with AEPa were analyzed by
LM and TEM. Morphological alterations were observed
in 100 μg/mL AEPa-treated cells that were characteristic
of activated cells. An increase in cytoplasmic area,
spreading ability and a high number of cytoplasmatic
projections were also observed (Figure 3b). Morphomet-
ric analysis showed significant increase in the area occu-
pied by cytoplasm in cells treated with AEPa, when
compared to the control group (Figure 3d).
To investigate possible ultrastructural changes in cells
treated with AEPa, TEM was performed. BMCs treated
with AEPa presented nuclei with abundant euchromatin,
an apparently increased number of endoplasmic reticuli
(ER), numerous mitochondria, which are characteristic
of intense cell metabolism, and numerous cellular pro-
jections (Figure 4c and d). The presence of cytoplasmic
vacuoles and structures suggestive of autophagic vacuolesFigure 3 Cytological evaluation of BMCs using Giemsa stain. Treated c
with 100 μg/mL AEPa, note the increased cell spreading, cytoplasmic volum
c) Cells treated with 100 nM of M-CSF. Cells after treatment with M-CSF pre
of the cells are undergoing cell fusion processes (head arrows). Scale bar 1
treated with AEPa or M-CSF, compared with control cells. Data are presentwere observed in the cytoplasm of AEPa-treated cells
(Figure 5a and b).
Induction of autophagy in BMCs
To test whether AEPa induces autophagy in BMCs, cells
were treated for 96 hours and the expression of LC3b
evaluated by flow cytometry. LC3b is a specific marker
for autophagy in mammalian cells; treated BMCs pre-
sented higher fluorescence intensity when compared to
the untreated control group. The staining of cells treated
with AEPa was similar to that of the control group after
starvation and to that of the group of cells treated with
M-CSF (Figures 5c-g).
Detection of cell surface markers by flow cytometry
To determine whether AEPa promotes the differenti-
ation of BMCs into macrophages, the expressions of the
surface proteins F4/80, CD11b and CD11c were assessed
on BMCs by flow cytometry. An increased of expression
of CD11b (Figure 6c) and F4/80 (Figure 6h and 6j) and
were observed on AEPa-treated cells. The same expres-
sion levels were observed in the positive-control groups,
consisting of peritoneal macrophages (Figure 6a, for
CD11b and 6f for F4/80) and BMCs stimulated with
M-CSF (Figure 6d for CD11b and 6i for F4/80), in com-
parison with untreated cells. Analysis of the fluores-
cence intensity showed that there was a decreased
staining of CD11b protein in AEPa-treated cells as alsoells were incubated for 96 hours. a) Untreated cells. b) Cells treated
e and cells with characteristics of activated macrophages (arrow).
sented a significant spreading ability, increased cellular area and most
0 μm. d) Morphometric analysis showed increased cell area for cells
ed as means ± SD, p < 0.05.
Figure 4 Ultrastructural analysis of BMCs. Treated cells were incubated for 96 hours. a) Untreated control. b) Cells treated with 100 nM M-CSF.
c, d) Cells treated with 100 μg/mL of AEPa. Cells treated with M-CSF and AEPa presented filopodia (arrows), cytoplasmic vacuoles (*), mitochondria and
abundant endoplasmic reticulae and presence of autophagic vacuoles (head arrows). Bars: 5 μm. N: Nucleus, M: Mitochondria, ER: Endoplasmic reticulum.
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macrophages (Figure 6e). Furthermore, CD11c labeling
showed no significant difference in levels expression com-
pared with untreated cells, AEPa treated cells or M-CSF
group (Additional file 2), showing that AEPa and M-CSF
does not stimulate the differentiation of BMCs into den-
dritic cells.
Discussion
A great number of herbal products have been used in
folk medicine due to their immunomodulatory actions
[15,16,25,26]. Extracts and physalins obtained from P.
angulata exhibit diverse biological properties, including,
analgesic, anti-inflammatory and immunomodulatory ac-
tivities [18,19,27-29]. AEPa exhibits beneficial effects on
carragenin-induced air pouch inflammation through its
immunomodulatory action [19]; however, the direct ac-
tion of AEPa on bone marrow remains unknown. Here,
we demonstrate for the first time that AEPa has an im-
munomodulatory effect on BMCs, differentiating cells
into macrophages. Chemical analyses from our group
have found that aqueous extracts of the dried root of P.
angulata contain physalins D, E, F and G (unpublished
data). We hypothesize that the immunomodulatoryeffects of AEPa may derive from the presence of these
physalins.
The differentiation of monocytes into macrophages or
DCs in culture is most commonly achieved during 5 days,
although a process of rapid differentiation within several
hours can occur, depending on the stimulus used [30].
These interesting effects indicate that bone marrow-
derived monocytes differentiate into macrophages; how-
ever, not all cell types respond in this same manner during
AEPa treatment.
A quantification experiment was performed to identify
the presence of different cell types in these cultures.
Lymphocyte numbers were found to be significantly re-
duced in BMCs treated with AEPa for 96 hours; as such,
AEPa does not stimulate the adhesion and proliferation
of this cell type. Bastos et al. [19] showed that AEPa had
an inhibitory effect on lymphocyte proliferation, particu-
larly on T cells. These results are in agreement with
those observed by Yu et al. [31], who demonstrated that
physalin H obtained from P. angulata presents an im-
munosuppressive activity, thus preventing the prolifera-
tion of T cells.
BMCs treated with AEPa showed a significant in-
crease of mononuclear cells when compared to control.
Figure 5 Detection of autophagic process in BMCs. Treated cells were incubated for 96 hours. a-b) Ultrastructural analysis of BMCs treated
with AEPa. Cells treated with AEPa presented autophagic vacuoles in the cytoplasm (arrows). Bars: 0.5 μm. c) Untreated control. d) Cells treated
with 100 μg/mL AEPa. e) Cells treated with 100 nM M-CSF. f) Starvation. g) Fluorescence intensity of BMCs stained with LC3b. ANOVA followed
by Tukey test, p <0.05.
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had a higher spread ability and morphometric analysis
revealed that treated cells showed an increase in cellular
area. In addition, TEM demonstrated that BMCs, treated
for 96 hours with 100 μg/mL AEPa, presented nuclei with
abundant euchromatin, augmented ER, elongated mito-
chondria and the presence of numerous cellular projections.
Several changes are observed during the process of differen-
tiation of monocytes into macrophages such as altered ex-
pression of surface proteins, increased cell size, increased
number of organelles and autophagic induction [8,9].
Another characteristic feature seen in AEPA- and M-
CSF-treated BMCs was the presence of autophagic vacu-
oles in the cytoplasm, which was not observed in untreated
cells. Analysis by flow cytometry revealed a significant in-
crease in LC3b protein on treated cells, when compared to
the control group, indicating an autophagy process.
Autophagy is very important during the process of
monocyte differentiation into macrophages, allowing
the proliferation of these cells and preventing death by
apoptosis [9]. The autophagic activation mechanism
can be induced by various routes, one of which is byER stress, and the response of the organism to autoph-
agy can be varied, allowing cell survival or leading to
non-apoptotic death [32,33]. Our results show that
AEPa-treated cells presented autophagic characteristics
and this mechanism was not deleterious to the cells,
since there was no reduction in cell viability. Thus, we
may suggest that autophagy favors cell survival, allow-
ing the differentiation of monocytes into macrophages.
Macrophages may elicit an altered pattern of surface
markers, as compared to non-differentiated cells. The
surface proteins, CD11b and F4/80, are examples of
molecules that change after macrophage differentiation
[34]. CD11b can be found on the surface of neutrophils,
DCs, lymphocytes and macrophages, but is highly
expressed on the monocyte surface [10]. However, the
F4/80 molecule is expressed only on the macrophage
surface [11]. Flow cytometry demonstrated a significant
decrease in CD11b levels on AEPa-treated cells when
compared to the control group. Results indicate that
monocytes were the most common cell type in the un-
treated BMCs, because this group had a high staining
for the CD11b protein. On the other hand, cells found
Figure 6 Expression of CD11b and F4/80 on BMCs. Treated cells were incubated for 96 hours. a-d) Detection of the CD11b surface marker by
flow cytometry. e) Fluorescence intensity of BMCs labeled with CD11b. f-i) Flow cytometric analysis of F4/80 surface marker. j) Fluorescence
intensity of BMCs stained with F4/80. ANOVA was followed by Tukey test, p <0.05.
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mainly macrophages as demonstrated by the decrease in
CD11b protein expression. To confirm that macro-
phages were the major cell type in the culture popula-
tion, expression of the macrophage-specific protein, F4/
80, was determined. There was a significant increase in
surface F4/80 on the AEPA-treated cells, where levels
were similar to those observed in the positive control
(peritoneal macrophages) and the M-CSF-treated group.
These results suggest that AEPa potentiates the differ-
entiation of monocytes into macrophages.
Another important immune cell type that is derived
from the monocyte lineage is the DCs; these are
antigen-presenting cells (APCs) that play a major role
in bridging of the innate and adaptative immune re-
sponses. When monocytes migrate to tissues they candifferentiate into macrophages or DCs [3]. In this
study, we have used the surface marker, CD11c, to de-
termine the presence of this cell type. No significant
difference in the expression levels for CD11c on AEPa-
treated BMCs was observed. Thus, AEPa was not able
to stimulate the differentiation and maturation of bone
marrow mononuclear cells in DCs. It is important to
emphasize that no cytotoxic effects were observed in
the cells treated with AEPa. The search for new prod-
ucts, without cytotoxic effects on mammalian cells, is
important for the development of agents that can induce
the differentiation and/or maturation of BMCs into
macrophages. Since these cells participate in the initiation
of the innate immune response, such agents may be able
to promote the protection against several intracellular
pathogens [12,26].
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AEPa seems to act on different aspects of cellular differ-
entiation, with potential to act as an immunomodulatory
agent, inducing the differentiation of BMCs into macro-
phages, which are important cells in the defense against
pathogens.
Additional files
Additional file 1: Flow citometry of unstained BMCs controls
elucidating gates for further analysis of treated cells.
Additional file 2: Detection of the CD11c surface marker by flow
cytometry on BMCs. Treated cells were incubated for 96 hours. a)
Untreated control. b) Cells treated with 100 μg/mL AEPa. c) Cells treated
with 100 nM M-CSF. d) Fluorescence intensity of BMCs labeled with
CD11c. ANOVA followed by Tukey test. p <0.05.
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